+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amphotericin B"

From
From
From
From
From
From
From
From
From
From
From
From
Global and Chinese Amphotericin B Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Amphotericin B Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 146 Pages
  • China, Global
From
Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021 - Product Thumbnail Image

Coccidioidomycosis (Infectious Disease) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 86 Pages
  • Global
From
From
Loading Indicator

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs. The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more